Literature DB >> 27458232

Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.

Jorgelina Morán-Barrio1, María-Natalia Lisa2, Nicole Larrieux3, Salvador I Drusin4, Alejandro M Viale1, Diego M Moreno5, Alejandro Buschiazzo6, Alejandro J Vila7.   

Abstract

Metallo-beta-lactamases (MBLs) are broad-spectrum, Zn(II)-dependent lactamases able to confer resistance to virtually every β-lactam antibiotic currently available. The large diversity of active-site structures and metal content among MBLs from different sources has limited the design of a pan-MBL inhibitor. GOB-18 is a divergent MBL from subclass B3 that is expressed by the opportunistic Gram-negative pathogen Elizabethkingia meningoseptica This MBL is atypical, since several residues conserved in B3 enzymes (such as a metal ligand His) are substituted in GOB enzymes. Here, we report the crystal structure of the periplasmic di-Zn(II) form of GOB-18. This enzyme displays a unique active-site structure, with residue Gln116 coordinating the Zn1 ion through its terminal amide moiety, replacing a ubiquitous His residue. This situation contrasts with that of B2 MBLs, where an equivalent His116Asn substitution leads to a di-Zn(II) inactive species. Instead, both the mono- and di-Zn(II) forms of GOB-18 are active against penicillins, cephalosporins, and carbapenems. In silico docking and molecular dynamics simulations indicate that residue Met221 is not involved in substrate binding, in contrast to Ser221, which otherwise is conserved in most B3 enzymes. These distinctive features are conserved in recently reported GOB orthologues in environmental bacteria. These findings provide valuable information for inhibitor design and also posit that GOB enzymes have alternative functions.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27458232      PMCID: PMC5038331          DOI: 10.1128/AAC.01067-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  55 in total

1.  Biochemical Characterization of CPS-1, a Subclass B3 Metallo-β-Lactamase from a Chryseobacterium piscium Soil Isolate.

Authors:  Dereje Dadi Gudeta; Simona Pollini; Jean-Denis Docquier; Valeria Bortolaia; Gian Maria Rossolini; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

2.  Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability.

Authors:  M Hernandez Valladares; A Felici; G Weber; H W Adolph; M Zeppezauer; G M Rossolini; G Amicosante; J M Frère; M Galleni
Journal:  Biochemistry       Date:  1997-09-23       Impact factor: 3.162

3.  New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition.

Authors:  Dustin T King; Liam J Worrall; Robert Gruninger; Natalie C J Strynadka
Journal:  J Am Chem Soc       Date:  2012-07-05       Impact factor: 15.419

Review 4.  Chryseobacterium meningosepticum sepsis complicated with retroperitoneal hematoma and pleural effusion in a diabetic patient.

Authors:  Shou-Wu Lee; Che-An Tsai; Bor-Jen Lee
Journal:  J Chin Med Assoc       Date:  2008-09       Impact factor: 2.743

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form.

Authors:  I Garcia-Saez; J-D Docquier; G M Rossolini; O Dideberg
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

7.  Probing the role of Met221 in the unusual metallo-β-lactamase GOB-18.

Authors:  María-Natalia Lisa; Jorgelina Morán-Barrio; María-Fernanda Guindón; Alejandro J Vila
Journal:  Inorg Chem       Date:  2012-10-31       Impact factor: 5.165

8.  Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.

Authors:  James Spencer; Jonathan Read; Richard B Sessions; Steven Howell; G Michael Blackburn; Steven J Gamblin
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

9.  Bacteremia due to Elizabethkingia meningoseptica.

Authors:  Takashi Shinha; Rakesh Ahuja
Journal:  IDCases       Date:  2015-01-17

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  12 in total

1.  Shaping Substrate Selectivity in a Broad-Spectrum Metallo-β-Lactamase.

Authors:  Lisandro J González; Cintia Stival; Juan L Puzzolo; Diego M Moreno; Alejandro J Vila
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 2.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

3.  QM/MM investigation of substrate binding of subclass B3 metallo-β-lactamase SMB-1 from Serratia marcescents: insights into catalytic mechanism.

Authors:  Xia Mu; Dingguo Xu
Journal:  J Mol Model       Date:  2020-03-07       Impact factor: 1.810

4.  Kinetic and Structural Characterization of the First B3 Metallo-β-Lactamase with an Active-Site Glutamic Acid.

Authors:  Liam A Wilson; Esmée G Knaven; Marc T Morris; Marcelo Monteiro Pedroso; Christopher J Schofield; Thomas B Brück; Mikael Boden; David W Waite; Philip Hugenholtz; Luke Guddat; Gerhard Schenk
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

5.  Crystal structure and kinetic analysis of the class B3 di-zinc metallo-β-lactamase LRA-12 from an Alaskan soil metagenome.

Authors:  María Margarita Rodríguez; Raphaël Herman; Barbara Ghiglione; Frédéric Kerff; Gabriela D'Amico González; Fabrice Bouillenne; Moreno Galleni; Jo Handelsman; Paulette Charlier; Gabriel Gutkind; Eric Sauvage; Pablo Power
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

6.  A general reaction mechanism for carbapenem hydrolysis by mononuclear and binuclear metallo-β-lactamases.

Authors:  María-Natalia Lisa; Antonela R Palacios; Mahesh Aitha; Mariano M González; Diego M Moreno; Michael W Crowder; Robert A Bonomo; James Spencer; David L Tierney; Leticia I Llarrull; Alejandro J Vila
Journal:  Nat Commun       Date:  2017-09-14       Impact factor: 14.919

7.  The draft genomes of Elizabethkingia anophelis of equine origin are genetically similar to three isolates from human clinical specimens.

Authors:  William L Johnson; Akhilesh Ramachandran; Nathanial J Torres; Ainsley C Nicholson; Anne M Whitney; Melissa Bell; Aaron Villarma; Ben W Humrighouse; Mili Sheth; Scot E Dowd; John R McQuiston; John E Gustafson
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

8.  Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.

Authors:  Youngchang Kim; Natalia Maltseva; Mateusz Wilamowski; Christine Tesar; Michael Endres; Andrzej Joachimiak
Journal:  Protein Sci       Date:  2019-12-24       Impact factor: 6.725

9.  2-Mercaptomethyl Thiazolidines (MMTZs) Inhibit All Metallo-β-Lactamase Classes by Maintaining a Conserved Binding Mode.

Authors:  Philip Hinchliffe; Diego M Moreno; Maria-Agustina Rossi; Maria F Mojica; Veronica Martinez; Valentina Villamil; Brad Spellberg; George L Drusano; Claudia Banchio; Graciela Mahler; Robert A Bonomo; Alejandro J Vila; James Spencer
Journal:  ACS Infect Dis       Date:  2021-08-06       Impact factor: 5.578

10.  Broad spectrum antibiotic-degrading metallo-β-lactamases are phylogenetically diverse.

Authors:  Marcelo Monteiro Pedroso; David W Waite; Okke Melse; Liam Wilson; Nataša Mitić; Ross P McGeary; Iris Antes; Luke W Guddat; Philip Hugenholtz; Gerhard Schenk
Journal:  Protein Cell       Date:  2020-08       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.